Incremental Prognostic Value of the Preoperative Controlling Nutritional Status Score in Patients Undergoing Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study
World Journal of Surgery · 2026-11-18
DOI: 10.1002/wjs.70693 ↗At a glance
Kohortenstudie in World Journal of Surgery, published online on 2026-11-18. Written by Karin Nakajima and 15 co-authors. 28 references.
Topics: Mangelernährung
Abstract (original language)
Background
The Controlling Nutritional Status (CONUT) score is a prognostic marker in pancreatic ductal adenocarcinoma (PDAC), but its incremental value beyond conventional preoperative factors and its performance relative to other immunonutritional or inflammatory indices remain unclear. We evaluated the prognostic significance and incremental value of the preoperative CONUT score in resectable PDAC.
Methods
This multicenter retrospective study included 287 patients with resectable PDAC undergoing curative‐intent pancreatectomy. Patients were stratified by preoperative CONUT score (0–1, 2–4, or ≥ 5). Overall survival (OS) and recurrence‐free survival (RFS) were analyzed using Cox models with preoperative factors. Recurrence was evaluated using Gray's test and Fine–Gray regression, with death before recurrence as a competing event. For model comparison, the CONUT score and other immunonutritional or inflammatory indices were added separately to the preoperative base model and evaluated using the concordance index (C‐index), Akaike information criterion (AIC), and likelihood ratio test.
Results
Five‐year OS was 51.5%, 31.5%, and 18.6% for CONUT scores of 0–1, 2–4, and ≥ 5, respectively ( p < 0.001). Higher CONUT categories were independently associated with worse OS (2–4, hazard ratio [HR] 1.604, p = 0.007; ≥ 5, HR 2.410, p < 0.001). Five‐year RFS was 42.6%, 23.2%, and 17.4%, respectively ( p < 0.001); higher CONUT categories remained independently associated with worse RFS (2–4, HR 1.543, p = 0.008; ≥ 5, HR 2.006, p = 0.002). Recurrence incidence increased with higher CONUT scores (Gray's test, p = 0.006). A high CONUT score (≥ 5) was independently associated with increased recurrence risk (subdistribution hazard ratio, 1.780; p = 0.022). Adding the CONUT score to the base model improved fit (C‐index, 0.629; AIC, 1802.53; likelihood ratio test, p < 0.001). The prognostic nutritional index (PNI) also improved fit, with modest differences versus the CONUT score.
Conclusions
The preoperative CONUT score was independently associated with OS and RFS after surgery for resectable PDAC and provided modest incremental prognostic information beyond conventional preoperative factors. A high CONUT score was associated with increased recurrence risk. These findings suggest that the CONUT score may help refine preoperative risk stratification.
Cite
APA
Nakajima, K., Sakata, J., Hirose, Y., Aono, T., Takizawa, K., Suzuki, S., Ishikawa, H., Maruyama, T., Ando, T., Abe, S., Kawachi, Y., Ichikawa, H., Nakano, M., Shimada, Y., Kobayashi, T., & Wakai, T. (2026). Incremental Prognostic Value of the Preoperative Controlling Nutritional Status Score in Patients Undergoing Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. World Journal of Surgery. https://doi.org/10.1002/wjs.70693
Vancouver
Nakajima K, Sakata J, Hirose Y, Aono T, Takizawa K, Suzuki S, et al. Incremental Prognostic Value of the Preoperative Controlling Nutritional Status Score in Patients Undergoing Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. World Journal of Surgery. 2026. doi:10.1002/wjs.70693
BibTeX
@article{Nakajima2026,
author = {Nakajima, Karin and Sakata, Jun and Hirose, Yuki and Aono, Takashi and Takizawa, Kazuyasu and Suzuki, Susumu and Ishikawa, Hirosuke and Maruyama, Tomohiro and Ando, Takuya and Abe, Shun and Kawachi, Yusuke and Ichikawa, Hiroshi and Nakano, Mae and Shimada, Yoshifumi and Kobayashi, Takashi and Wakai, Toshifumi},
title = {Incremental Prognostic Value of the Preoperative Controlling Nutritional Status Score in Patients Undergoing Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study},
journal = {World Journal of Surgery},
year = {2026},
doi = {10.1002/wjs.70693}
}
EUVIMED